Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about KRYS

Recent news which mentions KRYS

< Previous 1 2 3 Next >
Up 48% in 2023, Is This Biotech Stock a Buy?
Tickers KRYS
Tags Recent Press Releases KRYS Market News
From Motley Fool
Unlocking a $750 Million Opportunity: Krystal Biotech's Vyjuvek and its Potent Impact on Dystrophic Epidermolysis Bullosa Treatment
Tickers KRYS
Tags Benzinga General Analyst Ratings
From Benzinga
Why Shares of Krystal Biotech Are Rising Monday
Tickers KRYS
Tags Recent Press Releases KRYS Market News
From Motley Fool
Analyst Expectations for Krystal Biotech's Future
Tickers KRYS
Tags Benzinga KRYS Analyst Ratings
From Benzinga
FDA Approves First Redosable Gene Therapy, Krystal Biotech's Treatment For Skin Blistering Disorder
Tickers KRYS
Tags Briefs Offerings Market News
From Benzinga
NVIDIA To Rally Around 22%? Here Are 10 Other Analyst Forecasts For Monday
Tickers DKNG FL HIBB KRYS
Tags WMT Analyst Ratings PLCE
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
Tickers AQN ARCC ATER BAM
Tags RKLB WCN KRYS
From Benzinga
Expert Ratings for Krystal Biotech
Tickers KRYS
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday
Tickers AAON BFLY BHG CCO
Tags CLOV RVMD HY
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
Tickers ABCL ABNB ACLS AMTX
Tags ABNB HLLY ARNC
From Benzinga
Have A Look At William Blair's Top Biotech Picks For 2023
Tickers ALBO KDNY KRYS NBIX
Tags SGEN Briefs Small Cap
From Benzinga
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
Tickers ABBV ALT ARDX AXSM
Tags NYSE:XBI,NASDAQ:BIB,NYSE:ABBV,NASDAQ:AXSM,NASDAQ:ARDX,NASDAQ:ALT,NASDAQ:KRYS ABBV AXSM
From InvestorPlace
Krystal Biotech Epidermolysis Bullosa Study Data Published In New England Journal Of Medicine
Tickers KRYS
Tags Health Care Benzinga KRYS
From Benzinga
2 Risky Stocks That Could Soar in 2023
Tickers BLUE KRYS
Tags BLUE Market News KRYS
From Motley Fool
Krystal Biotech's Subsidiary Posts Durability Data For Fine Line, Wrinkles
Tickers KRYS
Tags Health Care Benzinga KRYS
From Benzinga
SolarEdge To Rally 54%? Plus This Analyst Predicts $1,335 For Mettler-Toledo International
Tickers EXAS GLP IAA INTA
Tags Price Target Analyst Ratings SEDG
From Benzinga
Cigna To $335? Plus This Analyst Slashes PT On Six Flags Entertainment By 25%
Tickers ACA CI KRYS NSSC
Tags Analyst Ratings QTWO Benzinga
From Benzinga
Recap: Krystal Biotech Q3 Earnings
Tickers KRYS
Tags BZI/Recaps Benzinga KRYS
From Benzinga
2 Growth Stocks That Could Double in the Next Year
Tickers BTAI EXEL KRYS
Tags Market News EXEL Recent Press Releases
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Tickers A ADPT ATNM AVBH
Tags DHR LEN PKI
From Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
Tickers AGLE BBIO BCRX CRIS
Tags Benzinga Biotech Catalysts / EOD Summary General
From Benzinga
FDA Accepts Krystal Biotech's Filing For Genetic Skin Disorder Candidate Under Priority Review
Tickers KRYS
Tags News General Health Care
From Benzinga
Krystal Biotech, Inc. (KRYS) Comes Up Short on Second Quarter EPS by 9 Cents. KRYS is trading at $83.08
Tickers KRYS
Tags KRYS News Analyst Rating
From Best Stocks
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
Tickers ABBV ACIU ALLR AXLA
Tags General ESPR XNCR
From Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
Tickers AERI AGEN ALXO BEAM
Tags KRYS Health Care BEAM
From Benzinga
Krystal Biotech Gets FDA Nod For Initial-Stage Lung Infection Study
Tickers KRYS
Tags News General FDA IND Approval
From Benzinga
Can This Healthcare Stock Keep Beating the Market?
Tickers KRYS
Tags KRYS Recent Press Releases Market News
From Motley Fool
Krystal Biotech Files To Seek Approval For Skin Disease Candidate
Tickers KRYS
Tags FDA Biotech Market News
From Benzinga
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
Tickers APLS ATHA BMRN CBIO
Tags GLPG Len Blavatnik Biotech
From Benzinga
The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial
Tickers ACAD ACST AURA AZN
Tags Biotech FDA AZN
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.